ALMS Alumis Inc. - Common Stock
$24,89
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 13, 2026
52W-Spanne
$4–$31
77% of range
Analystenbewertung
STRONG BUY
16 analysts
Kursziel
$40
+62% upside
P/E (TTM)
-3.4
ROE
-61.9%
Nettogewinnmarge
-1011.8%
ALMS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$24.89
Marktkapitalisierung
—
P/E (TTM)
-3.4
EPS (TTM)
$-2.86
Umsatz (TTM)
$24M
Dividendenrendite
—
ROE
-61.9%
Verschuldungsgrad
—
52W-Spanne
$4 – $31
ALMS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$24M
2025-12-31
→
2025-12-31
EPS
$-2.86
2023-12-31
→
2025-12-31
Freier Cashflow
$-370M
2025-12-31
→
2025-12-31
Margen
-1011.8%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ALMS
Peer-Median
P/E (TTM)
-3.4
38.7
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ALMS
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-1886.9%
—
Net Profit Margin (Nettogewinnmarge)
-1011.8%
15.3%
ROA
-64.6%
-6.4%
ROE
-61.9%
-16.8%
ROIC
-145.5%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ALMS
Peer-Median
Current Ratio (Liquiditätsgrad)
4.3
12.8
Quick Ratio
4.2
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ALMS
Peer-Median
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ALMS
Peer-Median
ALMS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
16 Analysten
- Starker Kauf 8 50,0%
- Kauf 6 37,5%
- Halten 2 12,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-19
Median
$39.00
← Unter allen Zielen
$24.89
Tief
$25.00
Hoch
$55.00
Median-Ziel
$39.00
+56,7%
Mittelwert-Ziel
$40.33
+62,1%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.10%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.74 | $-0.78 | 0.04% |
| 31. Dezember 2025 | $-0.94 | $-1.00 | 0.06% |
| 30. September 2025 | $-1.06 | $-0.93 | -0.13% |
| 30. Juni 2025 | $-1.68 | $-1.41 | -0.27% |
| 31. März 2025 | $-1.82 | $-1.52 | -0.30% |
| 31. Dezember 2024 | $-0.23 | $-1.42 | 1.2% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| MBX | $1.42B | -13.3 | — | — | -29.6% | — |
| AMLX | $1.33B | -7.9 | -77.1% | — | -61.2% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
| SUPN | $2.86B | -73.1 | 8.6% | -5.4% | -3.6% | — |
| ATAI | $223M | -1.4 | -1.9% | -48464.0% | -83.1% | — |
| TRVI | $1.61B | -39.1 | — | — | -22.4% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | 2025 |
|---|---|---|
| Revenue | $24M | |
| R&D Expense | $386M | |
| SG&A Expense | $92M | |
| Operating Expenses | $478M | |
| Operating Income | $-454M | |
| Other Non-op | $-169.0K | |
| Pretax Income | $-252M | |
| Income Tax | $-9M | |
| Net Income | $-243M | |
| EPS (Basic) | $-2.86 | |
| EPS (Diluted) | $-2.86 | |
| Shares (Basic) | 85,029,624 | |
| Shares (Diluted) | 85,029,624 | |
| EBITDA | $-450M |
Bilanz 20
| Kennzahl | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $90M | |
| Short-term Investments | $219M | |
| Prepaid Expense | $7M | |
| Current Assets | $318M | |
| PP&E (Net) | $18M | |
| PP&E (Gross) | $26M | |
| Accum. Depreciation | $8M | |
| Other Non-current Assets | $6M | |
| Total Assets | $412M | |
| Accounts Payable | $10M | |
| Current Liabilities | $73M | |
| Capital Leases | $32M | |
| Deferred Tax | $2M | |
| Other Non-current Liabilities | $207.0K | |
| Total Liabilities | $111M | |
| Paid-in Capital | $1.20B | |
| Retained Earnings | $-902M | |
| AOCI | $188.0K | |
| Stockholders' Equity | $301M | |
| Liabilities + Equity | $412M |
Cashflow 11
| Kennzahl | Trend | 2025 |
|---|---|---|
| D&A | $3M | |
| Stock-based Comp | $44M | |
| Deferred Tax | $-9M | |
| Other Non-cash | $-165M | |
| Operating Cash Flow | $-370M | |
| CapEx | $653.0K | |
| Investing Cash Flow | $288M | |
| Stock Repurchased | $17.0K | |
| Net Stock Activity | $-17.0K | |
| Financing Cash Flow | $2M | |
| Free Cash Flow | $-370M |
Rentabilität 7
| Kennzahl | Trend | 2025 |
|---|---|---|
| Operating Margin | -1886.9% | |
| Net Margin | -1011.8% | |
| Pretax Margin | -1047.3% | |
| EBITDA Margin | -1872.4% | |
| ROA | -64.6% | |
| ROE | -61.9% | |
| ROIC | -145.5% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 |
|---|---|---|
| Current Ratio | 4.3 | |
| Quick Ratio | 4.2 |
Effizienz 1
| Kennzahl | Trend | 2025 |
|---|---|---|
| Asset Turnover | 0.1 |
Bewertung (TTM) 4
| Kennzahl | Trend | 2025 |
|---|---|---|
| Revenue TTM | $24M | |
| Net Income TTM | $-243M | |
| P/E | -3.4 | |
| Earnings Yield | -29.3% |
Gewinn- und Verlustrechnung 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $2M | $2M | $2M | $3M | $17M | |
| R&D Expense | $85M | $82M | $83M | $98M | $109M | $97M | |
| SG&A Expense | $23M | $19M | $16M | $20M | $34M | $22M | |
| Operating Expenses | $151M | $100M | $98M | $117M | $143M | $119M | |
| Operating Income | $-149M | $-98M | $-96M | $-115M | $-141M | $-102M | |
| Other Non-op | $-71.0K | $7.0K | $-33.0K | $-54.0K | $-38.0K | $-44.0K | |
| Pretax Income | $-144M | · | $-93M | $-111M | $51M | · | |
| Income Tax | $-2M | · | $0 | $0 | $-9M | · | |
| Net Income | $-142M | $-93M | $-93M | $-111M | $59M | $-99M | |
| EPS (Basic) | $-1.11 | $-0.74 | $-0.76 | $-1.06 | $0.78 | $-1.82 | |
| EPS (Diluted) | $-1.11 | $-0.74 | $-0.75 | $-1.06 | $0.77 | $-1.82 | |
| Shares (Basic) | 127,690,254 | 125,050,645 | -149,837,027 | 104,109,243 | 76,477,144 | 54,280,264 | |
| Shares (Diluted) | 127,690,254 | 125,050,645 | -149,995,778 | 104,109,243 | 76,635,895 | 65,440,021 | |
| EBITDA | $-149M | $-98M | · | $-115M | $-141M | $-101M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $64M | $64M | $90M | $65M | $152M | $129M | |
| Short-term Investments | · | · | $219M | $312M | $335M | $80M | |
| Prepaid Expense | $7M | $6M | $7M | $11M | $24M | $4M | |
| Current Assets | $514M | $532M | $318M | $393M | $518M | $226M | |
| PP&E (Net) | $17M | $18M | $18M | $19M | $20M | $20M | |
| PP&E (Gross) | $27M | $26M | $26M | $26M | $27M | $26M | |
| Accum. Depreciation | $10M | $9M | $8M | $7M | $7M | $5M | |
| Other Non-current Assets | $2M | $7M | $6M | $6M | $2M | $45.0K | |
| Total Assets | $561M | $672M | $412M | $488M | $611M | $261M | |
| Accounts Payable | $13M | $12M | $10M | $5M | $15M | $7M | |
| Current Liabilities | $76M | $71M | $73M | $65M | $86M | $60M | |
| Capital Leases | $32M | $31M | $32M | $33M | $35M | $29M | |
| Deferred Tax | $383.0K | $2M | $2M | $2M | $2M | · | |
| Other Non-current Liabilities | $168.0K | $207.0K | $207.0K | $169.0K | $168.0K | · | |
| Total Liabilities | $108M | $105M | $111M | $103M | $126M | $93M | |
| Paid-in Capital | $1.59B | $1.56B | $1.20B | $1.19B | $1.18B | $926M | |
| Retained Earnings | $-1.14B | $-995M | $-902M | $-809M | $-698M | $-758M | |
| AOCI | $-683.0K | $-467.0K | $188.0K | $234.0K | $22.0K | $-8.0K | |
| Stockholders' Equity | $452M | $567M | $301M | $385M | $485M | $168M | |
| Liabilities + Equity | $561M | $672M | $412M | $488M | $611M | $261M |
Cashflow 11
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| D&A | $874.0K | $871.0K | $867.0K | $916.0K | $870.0K | $843.0K | |
| Stock-based Comp | $14M | $12M | $8M | $10M | $19M | $7M | |
| Other Non-cash | · | $-7M | · | · | · | $11M | |
| Operating Cash Flow | $-82M | $-87M | $-72M | $-111M | $-106M | $-80M | |
| CapEx | $237.0K | $164.0K | $0 | $0 | $616.0K | $37.0K | |
| Investing Cash Flow | $69M | $-286M | $95M | $24M | $129M | $39M | |
| Stock Issued | $0 | $324M | · | · | · | · | |
| Stock Repurchased | · | · | $0 | $0 | · | · | |
| Net Stock Activity | · | $324M | · | · | · | · | |
| Financing Cash Flow | $13M | $347M | $1M | $0 | · | · | |
| Free Cash Flow | · | $-87M | · | · | · | $-80M |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -8956.4% | -5652.4% | · | -5580.4% | -5271.5% | -583.9% | |
| Net Margin | -8557.2% | -5344.8% | · | -5360.7% | 2225.1% | -569.1% | |
| Pretax Margin | -8662.9% | · | · | -5360.7% | 1904.0% | · | |
| EBITDA Margin | -8956.4% | -5602.4% | · | -5580.4% | -5271.5% | -579.0% | |
| ROA | -24.3% | -20.0% | · | -24.6% | 13.5% | -75.8% | |
| ROE | -30.3% | -25.3% | · | -30.2% | 254.8% | -117.6% | |
| ROIC | -32.5% | · | · | -30.0% | -33.8% | · |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 6.7 | 7.5 | · | 6.0 | 6.0 | 3.7 | |
| Quick Ratio | 0.8 | 0.9 | · | 5.8 | 5.7 | 3.5 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 |
Bewertung (TTM) 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $8M | $24M | · | · | · | · | |
| Net Income TTM | $-287M | $-243M | · | $-244M | $-189M | $-298M | |
| P/E | -13.1 | -7.7 | · | -1.0 | -0.1 | -0.1 | |
| Earnings Yield | -7.6% | -12.9% | · | -96.2% | -862.7% | -776.6% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Umsatz | $24M | — | — |
| Betriebsgewinnmarge % | -1886.9% | — | — |
| Nettoergebnis | $-243M | $-294M | $-155M |
| Verwässerte EPS | $-2.86 | $-10.38 | $-72.08 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Liquiditätsgrad | 4.3 | — | — |
| Quick Ratio | 4.2 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | |
|---|---|---|---|
| Freier Cashflow | $-370M | — | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
- Diese Biotech-Aktie ist um 355 % gestiegen. Ein Fonds hat im letzten Quartal eine Position von 169 Millionen US-Dollar aufgebaut.
- Alumis-Aktie steigt um über 300 %. Ein wichtiger Investor im Gesundheitswesen reduziert seine Beteiligung
- Warum der 4-Millionen-Dollar-Kauf von Alumis durch einen Fonds wie eine Wette auf ein bahnbrechendes Medikament gegen Autoimmunerkrankungen aussieht
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 219 Einreicher · $2.8B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 32 (-60 vs. Vorquartal) | 20 (-1 vs. Vorquartal) | 75 (+13 vs. Vorquartal) | 64 (+30 vs. Vorquartal) | +12.9M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| AyurMaya Capital Management Company, LP | $426.031.355 | 15.139.707 | 15,31% | Aktien |
| Deep Track Capital, LP | $178.648.422 | 6.348.558 | 6,42% | Aktien |
| SAMSARA BIOCAPITAL, LLC | $178.554.463 | 6.345.219 | 6,42% | Aktien |
| FMR LLC | $167.396.981 | 5.948.720 | 6,02% | Aktien |
| Foresite Capital Management V, LLC | $165.941.439 | 5.896.995 | 5,96% | Aktien |
| venBio Partners LLC | $127.429.401 | 4.528.408 | 4,58% | Aktien |
| Foresite Capital Management VI LLC | $119.529.434 | 4.247.670 | 4,30% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $118.629.882 | 4.215.703 | 4,26% | Aktien |
| Nextech Invest Ltd. | $99.643.684 | 3.540.998 | 3,58% | Aktien |
| Cormorant Asset Management, LP | $92.456.671 | 3.285.596 | 3,32% | Aktien |
| Saturn V Capital Management LP | $82.040.566 | 2.915.443 | 2,95% | Aktien |
| Octagon Capital Advisors LP | $79.655.898 | 2.830.700 | 2,86% | Aktien |
| STATE STREET CORP | $61.549.665 | 2.187.266 | 2,21% | Aktien |
| MPM BIOIMPACT LLC | $56.815.223 | 2.019.020 | 2,04% | Aktien |
| BAKER BROS. ADVISORS LP | $56.631.750 | 2.012.500 | 2,04% | Aktien |
| SR One Capital Management, LP | $55.151.473 | 1.959.896 | 1,98% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $52.423.177 | 1.862.525 | 1,88% | Aktien |
| JANUS HENDERSON GROUP PLC | $46.151.361 | 2.095.408 | 1,66% | Aktien |
| NOVO HOLDINGS A/S | $30.954.000 | 1.100.000 | 1,11% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $29.885.271 | 1.062.021 | 1,07% | Aktien |
| D. E. Shaw & Co., Inc. | $27.246.105 | 968.234 | 0,98% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $25.922.878 | 921.211 | 0,93% | Aktien |
| Ikarian Capital, LLC | $24.497.220 | 870.548 | 0,88% | Aktien |
| GREAT POINT PARTNERS LLC | $24.089.557 | 856.061 | 0,87% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.701.771 | 700.134 | 0,71% | Aktien |
| Integral Health Asset Management, LLC | $19.698.000 | 700.000 | 0,71% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $18.576.396 | 660.142 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $17.221.961 | 612.010 | 0,62% | Aktien |
| Opaleye Management Inc. | $15.477.000 | 550.000 | 0,56% | Aktien |
| ORBIMED ADVISORS LLC | $15.425.307 | 548.163 | 0,55% | Aktien |
| GOLDMAN SACHS GROUP INC | $15.172.778 | 539.189 | 0,55% | Aktien |
| ROYCE & ASSOCIATES LP | $14.782.026 | 525.303 | 0,53% | Aktien |
| Woodline Partners LP | $13.677.503 | 486.052 | 0,49% | Aktien |
| Nextech Invest Ltd. | $11.609.204 | 1.476.998 | 0,42% | Aktien |
| Spruce Street Capital LP | $11.047.032 | 392.574 | 0,40% | Aktien |
| Trium Capital LLP | $10.982.142 | 390.268 | 0,39% | Aktien |
| CITIGROUP INC | $10.697.196 | 380.142 | 0,38% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $10.583.989 | 376.119 | 0,38% | Aktien |
| Ikarian Capital, LLC | $10.026.282 | 356.300 | 0,36% | Kaufoption |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $9.029.029 | 320.861 | 0,32% | Aktien |
| Weiss Asset Management LP | $8.761.980 | 311.371 | 0,31% | Aktien |
| Artia Global Partners LP | $7.838.284 | 278.546 | 0,28% | Aktien |
| Yu Fan | $7.110.190 | 252.672 | 0,26% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $6.825.019 | 242.538 | 0,25% | Aktien |
| Omega Fund Management, LLC | $6.788.916 | 241.255 | 0,24% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $6.413.806 | 236.323 | 0,23% | Aktien |
| TOWERVIEW LLC | $6.255.353 | 222.294 | 0,22% | Aktien |
| JPMORGAN CHASE & CO | $5.970.230 | 216.591 | 0,21% | Aktien |
| Exome Asset Management LLC | $5.752.323 | 204.418 | 0,21% | Aktien |
| DIADEMA PARTNERS LP | $5.628.000 | 200.000 | 0,20% | Kaufoption |
| HighVista Strategies LLC | $5.627.100 | 199.968 | 0,20% | Aktien |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | $5.583.008 | 1.399.250 | 0,20% | Aktien |
| MARSHALL WACE, LLP | $5.458.767 | 193.986 | 0,20% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.409.184 | 192.224 | 0,19% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $4.862.001 | 172.779 | 0,17% | Aktien |
| BlackRock, Inc. | $4.784.841 | 170.037 | 0,17% | Aktien |
| Ensign Peak Advisors, Inc | $4.135.736 | 146.970 | 0,15% | Aktien |
| VANGUARD GROUP INC | $3.906.303 | 400.236 | 0,14% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $3.849.636 | 136.803 | 0,14% | Aktien |
| Swiss National Bank | $3.824.226 | 135.900 | 0,14% | Aktien |
| STEMPOINT CAPITAL LP | $3.819.611 | 135.736 | 0,14% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $3.795.000 | 134.850 | 0,14% | Aktien |
| VICTORY CAPITAL MANAGEMENT INC | $3.723.794 | 132.331 | 0,13% | Aktien |
| Quantinno Capital Management LP | $3.688.929 | 131.092 | 0,13% | Aktien |
| Elmind Capital, LP | $3.658.200 | 130.000 | 0,13% | Aktien |
| PRUDENTIAL FINANCIAL INC | $3.474.812 | 123.483 | 0,12% | Aktien |
| WELLS FARGO & COMPANY/MN | $3.145.377 | 111.776 | 0,11% | Aktien |
| STIFEL FINANCIAL CORP | $3.097.510 | 110.075 | 0,11% | Aktien |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.943.444 | 104.600 | 0,11% | Kaufoption |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2.820.050 | 100.215 | 0,10% | Aktien |
| Caption Management, LLC | $2.814.000 | 100.000 | 0,10% | Kaufoption |
| Ghisallo Capital Management LLC | $2.814.000 | 100.000 | 0,10% | Aktien |
| TD Asset Management Inc | $2.729.636 | 97.002 | 0,10% | Aktien |
| RHUMBLINE ADVISERS | $2.723.010 | 96.767 | 0,10% | Aktien |
| FIRST TRUST ADVISORS LP | $2.646.454 | 94.046 | 0,10% | Aktien |
| Harvest Investment Services, LLC | $2.610.407 | 92.765 | 0,09% | Aktien |
| BARCLAYS PLC | $2.596.309 | 92.264 | 0,09% | Aktien |
| Caption Management, LLC | $2.532.600 | 90.000 | 0,09% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.490.390 | 88.500 | 0,09% | Kaufoption |
| ALLIANCEBERNSTEIN L.P. | $2.299.800 | 104.394 | 0,08% | Aktien |
| Ally Bridge Group (NY) LLC | $2.151.556 | 76.459 | 0,08% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2.040.150 | 72.500 | 0,07% | Verkaufsoption |
| Mariner, LLC | $2.018.263 | 71.726 | 0,07% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.781.015 | 80.845 | 0,06% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $1.725.657 | 61.324 | 0,06% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.652.296 | 58.717 | 0,06% | Aktien |
| ALGERT GLOBAL LLC | $1.625.648 | 57.770 | 0,06% | Aktien |
| CITADEL ADVISORS LLC | $1.581.468 | 56.200 | 0,06% | Kaufoption |
| ACT CAPITAL MANAGEMENT, LLC | $1.452.024 | 51.600 | 0,05% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.424.306 | 50.615 | 0,05% | Aktien |
| STATE OF WISCONSIN INVESTMENT BOARD | $1.418.622 | 50.413 | 0,05% | Aktien |
| Vanguard Global Advisers, LLC | $1.400.134 | 49.756 | 0,05% | Aktien |
| Squarepoint Ops LLC | $1.339.183 | 47.590 | 0,05% | Aktien |
| MetLife Investment Management, LLC | $1.303.220 | 46.312 | 0,05% | Aktien |
| CITADEL ADVISORS LLC | $1.224.090 | 43.500 | 0,04% | Verkaufsoption |
| FRED ALGER MANAGEMENT, LLC | $1.211.624 | 43.057 | 0,04% | Aktien |
| JANE STREET GROUP, LLC | $1.136.856 | 40.400 | 0,04% | Verkaufsoption |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.023.536 | 36.373 | 0,04% | Aktien |
| Corient Private Wealth LP | $997.142 | 35.435 | 0,04% | Aktien |
| Trexquant Investment LP | $960.615 | 34.137 | 0,03% | Aktien |
Unternehmensinsider 12 Insider · 0 Führungskräfte · 6 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Lynn A. Tetrault | Direktor | 30. Juni 2026 A | 3.553 | 0 | 0 | $0 |
| Sapna Srivastava | Direktor | 30. Juni 2026 A | 3.553 | 0 | 0 | $0 |
| Zhengbin Yao | Direktor | 30. Juni 2026 A | 27.082 | 0 | 0 | $0 |
| Patrick Machado | Direktor | 30. Juni 2026 A | 3.553 | 0 | 0 | $0 |
| Srinivas Akkaraju | Direktor | 30. Juni 2026 A | 3.553 | 15 | 0 | $19.069.488 |
| James B. Tananbaum | Direktor | 1. April 2026 J | 680.486 | 7 | 0 | $10.627.638 |
| Sanam Pangali | — | 3. August 2026 S | 9.747 | 0 | 2 | $-175.969 |
| Mark Christopher Bradley | — | 3. August 2026 S | 48.533 | 0 | 1 | $-67.824 |
| Jorn Drappa | — | 3. August 2026 S | 56.892 | 0 | 1 | $-64.527 |
| David M Goldstein | — | 3. August 2026 S | 30.970 | 0 | 1 | $-68.457 |
| John R. Schroer | — | 3. August 2026 S | 24.718 | 0 | 1 | $-86.546 |
| Roy C. Hardiman | — | 3. August 2026 S | 207.746 | 0 | 1 | $-70.988 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Foresite Capital Fund VI LP, Foresite Capital Management VI, LLC, Foresite Capital Fund V, L.P., Foresite Capital Management V, LLC, Foresite Capital Opportunity Fund V, L.P., Foresite Capital Opportunity Management V, LLC, James B. Tananbaum ×5 Einreichungen | 17. August 2026 | 14,50% | Erste Einreichung | Passive Anlage | SEC |
| AyurMaya Capital Management Company, LP, David E. Goel ×4 Einreichungen | 2. Juli 2026 | 12,30% | Änderung | — | SEC |
| Samsara BioCapital, L.P., Samsara BioCapital GP, LLC, Samsara Opportunity Fund, L.P., Samsara Opportunity Fund GP, LLC, Srinivas Akkaraju ×5 Einreichungen | 13. Januar 2026 | 5,40% | Änderung | — | SEC |
| Foresite Capital Fund VI, L.P. (“Fund VI”), Foresite Capital Management VI, LLC (“FCM VI”), Foresite Capital Fund V, L.P. (“Fund V”), Labs Co-Invest V, LLC (“Labs Co-Invest”), Foresite Capital Management V, LLC (“FCM V”), Foresite Capital Opportunity Fund V, L.P. (“Opportunity Fund V”), Foresite Capital Opportunity Management V, LLC (“FCOM V”), Foresite Labs Fund I, L.P. (“Labs Fund I”), Foresite Labs Management I, LLC (“FLM I”), Foresite Labs Affiliates 2021, LLC (“Labs Affiliates”), Foresite Labs, LLC (“Labs”), James B. Tananbaum (“Tananbaum”) | 5. Juli 2024 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 38 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,59% | 24.020 NS | 30. April 2026 | N-PORT |
| PILL · Direxion Shares ETF Trust | 1,25% | 6.551 NS | 30. April 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,54% | 2.446 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 0,52% | 304.339 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,23% | 6.715 SH | 8. August 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 126.318 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,18% | 613.997 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,14% | 4.674 NS | 31. Mai 2026 | N-PORT |
| IWO · iShares Trust | 0,14% | 718.737 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 84.673 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,10% | 99.832 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,07% | 454.674 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,07% | 2.015.040 SH | 8. August 2026 | Täglich |
| SMMV · iShares Trust | 0,06% | 6.398 SH | 8. August 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 61.746 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,04% | 3.225 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,04% | 389.927 NS | 31. Mai 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 3.324 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 976.842 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,03% | 203.834 SH | 8. August 2026 | Täglich |
| GSSC · Goldman Sachs ETF Trust | 0,03% | 11.873 NS | 31. Mai 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 29.655 NS | 30. April 2026 | N-PORT |
| UWM · ProShares Trust | 0,02% | 2.523 NS | 31. Mai 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 3.939 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,02% | 2.551 NS | 31. Mai 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,01% | 9.842 NS | 31. Mai 2026 | N-PORT |
| ONEQ · Fidelity Commonwealth Trust | 0,01% | 33.350 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 64 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 1.965 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 113.351 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 22.996 SH | 8. August 2026 | Täglich |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 46.445 NS | 31. Mai 2026 | N-PORT |
| AVSU · AMERICAN CENTURY ETF TRUST | 0,00% | 60 NS | 31. Mai 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 1.484 NS | 31. Mai 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 612 NS | 30. April 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.140.764 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 6.510 SH | 8. August 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,00% | 1 NS | 30. April 2026 | N-PORT |